Literature DB >> 18326494

Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging.

Meirav Zaks-Zilberman1, Adrian E Harrington, Tetsuya Ishino, Irwin M Chaiken.   

Abstract

Interleukin (IL)-5 exerts hematopoietic functions through binding to the IL-5 receptor subunits, alpha and betac. Specific assembly steps of full-length subunits as they occur in cell membranes, ultimately leading to receptor activation, are not well understood. We tracked the oligomerization of IL-5 receptor subunits using fluorescence resonance energy transfer (FRET) imaging. Full-length IL-5Ralpha and betac were expressed in Phoenix cells as chimeric proteins fused to enhanced cyan or yellow fluorescent protein (CFP or YFP, respectively). A time- and dose-dependent increase in FRET signal between IL-5Ralpha-CFP and betac-YFP was observed in response to IL-5, indicative of heteromeric receptor alpha-betac subunit interaction. This response was inhibited by AF17121, a peptide antagonist of IL-5Ralpha. Substantial FRET signals with betac-CFP and betac-YFP co-expressed in the absence of IL-5Ralpha demonstrated that betac subunits exist as preformed homo-oligomers. IL-5 had no effect on this betac-alone FRET signal. Interestingly, the addition of IL-5 to cells co-expressing betac-CFP, betac-YFP, and nontagged IL-5Ralpha led to further increase in FRET efficiency. Observation of preformed betac oligomers fits with the view that this form can lead to rapid cellular responses upon IL-5 stimulation. The IL-5-induced effects on betac assembly in the presence of nontagged IL-5Ralpha provide direct evidence that IL-5 can cause higher order rearrangements of betac homo-oligomers. These results suggest that IL-5 and perhaps other betac cytokines (IL-3 and granulocyte/macrophage colony-stimulating factor) trigger cellular responses by the sequential binding of cytokine ligand to the specificity receptor (subunit alpha), followed by binding of the ligand-subunit alpha complex to, and consequent rearrangement of, a ground state form of betac oligomers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326494      PMCID: PMC2442328          DOI: 10.1074/jbc.M710230200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  An improved resolution structure of the human beta common receptor involved in IL-3, IL-5 and GM-CSF signalling which gives better definition of the high-affinity binding epitope.

Authors:  P D Carr; F Conlan; S Ford; D L Ollis; I G Young
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-05-31

2.  The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor exists as a preformed receptor complex that can be activated by GM-CSF, interleukin-3, or interleukin-5.

Authors:  J M Woodcock; B J McClure; F C Stomski; M J Elliott; C J Bagley; A F Lopez
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

3.  Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study.

Authors:  S Damjanovich; L Bene; J Matkó; A Alileche; C K Goldman; S Sharrow; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  IL-3, IL-5, and GM-CSF signaling: crystal structure of the human beta-common receptor.

Authors:  James M Murphy; Ian G Young
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

5.  Ligand-independent cell surface expression of the human soluble granulocyte-macrophage colony-stimulating factor receptor alpha subunit depends on co-expression of the membrane-associated receptor beta subunit.

Authors:  E W Murray; C Pihl; A Morcos; C B Brown
Journal:  J Biol Chem       Date:  1996-06-28       Impact factor: 5.157

6.  Identification of a Cys motif in the common beta chain of the interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 receptors essential for disulfide-linked receptor heterodimerization and activation of all three receptors.

Authors:  F C Stomski; J M Woodcock; B Zacharakis; C J Bagley; Q Sun; A F Lopez
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

7.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells.

Authors:  S Watanabe; T Itoh; K Arai
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

9.  A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands.

Authors:  J M Woodcock; C J Bagley; B Zacharakis; A F Lopez
Journal:  J Biol Chem       Date:  1996-10-18       Impact factor: 5.157

10.  The beta subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the alpha subunit.

Authors:  A Muto; S Watanabe; A Miyajima; T Yokota; K Arai
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

2.  Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.

Authors:  Stephan Wilmes; Maximillian Hafer; Joni Vuorio; Julie A Tucker; Hauke Winkelmann; Sara Löchte; Tess A Stanly; Katiuska D Pulgar Prieto; Chetan Poojari; Vivek Sharma; Christian P Richter; Rainer Kurre; Stevan R Hubbard; K Christopher Garcia; Ignacio Moraga; Ilpo Vattulainen; Ian S Hitchcock; Jacob Piehler
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

Review 3.  Benralizumab--a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity--a novel approach for the treatment of asthma.

Authors:  Aasia Ghazi; Anita Trikha; William J Calhoun
Journal:  Expert Opin Biol Ther       Date:  2011-12-05       Impact factor: 4.388

4.  Structural basis of interleukin-5 dimer recognition by its α receptor.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Nobumasa Hino; Noboru Ohsawa; Masashi Ikutani; Satoshi Takaki; Kensaku Sakamoto; Miki Hara-Yokoyama; Mikako Shirouzu; Kiyoshi Takatsu; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2012-04-23       Impact factor: 6.725

5.  Dynamic Modulation of Binding Affinity as a Mechanism for Regulating Interferon Signaling.

Authors:  Hongchun Li; Nanaocha Sharma; Ignacio J General; Gideon Schreiber; Ivet Bahar
Journal:  J Mol Biol       Date:  2017-06-23       Impact factor: 5.469

6.  Four-color single-molecule imaging with engineered tags resolves the molecular architecture of signaling complexes in the plasma membrane.

Authors:  Junel Sotolongo Bellón; Oliver Birkholz; Christian P Richter; Florian Eull; Hella Kenneweg; Stephan Wilmes; Ulrich Rothbauer; Changjiang You; Mark R Walter; Rainer Kurre; Jacob Piehler
Journal:  Cell Rep Methods       Date:  2022-02-04

Review 7.  Understanding cytokine and growth factor receptor activation mechanisms.

Authors:  Mariya Atanasova; Adrian Whitty
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

8.  Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain.

Authors:  Nanaocha Sharma; Geeta Longjam; Gideon Schreiber
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

Review 9.  Interleukin-5 and IL-5 receptor in health and diseases.

Authors:  Kiyoshi Takatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

10.  Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.

Authors:  Stephan Wilmes; Oliver Beutel; Zhi Li; Véronique Francois-Newton; Christian P Richter; Dennis Janning; Cindy Kroll; Patrizia Hanhart; Katharina Hötte; Changjiang You; Gilles Uzé; Sandra Pellegrini; Jacob Piehler
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.